Acute Stroke: Clinical Trials

7 trials for Acute Stroke, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 7 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 37Completed 7
Phase 23Completed 3

Follow Acute Stroke: new trials by email Literature Review of Acute Stroke trials Research Report on Acute Stroke

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Optimizing Early Nutrition Support in Severe Stroke-2
Trophic enteral feeding combined with supplemental parenteral nutrition, Full enteral feeding - Severe Stroke, Acute Stroke
Phase 3CompletedWen Jiang-35462023-12-202026-06-24
Ticagrelol Versus Aspirin in Ischemic Stroke
Ticagrelor (Brilique) 90, Aspirin 75mg - Acute Stroke, Ischemic Stroke
Phase 3CompletedKafrelsheikh University1692019-05-012021-09-02
Safety and Efficacy of Glibenclamide Combined With Rt-PA in Acute Cerebral Embolism
Glibenclamide, Placebo - Acute Stroke
Phase 2 / Phase 3CompletedNanfang Hospital, Southern Medical University3062018-01-012023-06-12
Blood Pressure Control in Acute Ischemic Stroke
Early intensive BP control - Blood Pressure, Acute Stroke
Phase 2 / Phase 3CompletedNational University of Singapore542014-12-012019-04-16
New Acute Treatment for Stroke - The Effect of Remote PERconditioning
Actilyse, Thrombolysis + remote perconditioning - Acute Stroke
Phase 3CompletedAarhus University Hospital1202009-07-012011-06-23
Efficacy and Safety of Continuous Intravenous Versus Usual Subcutaneous Insulin in Acute Ischemic Stroke
Insulin - Acute Stroke, Acute Cerebral Ischemia
Phase 2 / Phase 3CompletedAssistance Publique - Hôpitaux de Paris1802007-05-012014-06-05
Intravenous Ancrod for the Treatment of Acute Ischemic Stroke Within 6 Hours After Onset of Symptoms
Ancrod - Brain Infarction, Cerebral Ischemia
Phase 3CompletedHeidelberg University2006-06-22

Narrower conditions

Stroke (7)  ·  Ischemic Stroke (3)  ·  Brain Edema (1)  ·  Brain Infarction (1)  ·  Brain Ischemia (1)  ·  Deglutition Disorders (1)  ·  Insulin Resistance (1)  ·  Pneumonia (1)  ·  Vascular Diseases (1)

Broader conditions

Brain Diseases (7)  ·  Cardiovascular Diseases (7)  ·  Central Nervous System Diseases (7)  ·  Cerebrovascular Disorders (7)  ·  Nervous System Diseases (7)  ·  Vascular Diseases (6)  ·  Digestive System Diseases (1)  ·  Esophageal Diseases (1)  ·  Gastrointestinal Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Hyperinsulinism (1)  ·  Infarction (1)  ·  Infections (1)  ·  Ischemia (1)  ·  Lung Diseases (1)

Interventions

Ancrod (1)  ·  Aspirin (1)  ·  Fibrinolytic Agents (1)  ·  Glyburide (1)  ·  Insulin (1)  ·  Ticagrelor (1)  ·  Tissue Plasminogen Activator (1)

Sponsors

Aarhus University Hospital (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Heidelberg University (1)  ·  Kafrelsheikh University (1)  ·  Nanfang Hospital, Southern Medical University (1)  ·  National University of Singapore (1)  ·  Wen Jiang-3 (1)

Countries

China (2)  ·  Denmark (1)  ·  Egypt (1)  ·  France (1)  ·  Singapore (1)

Top investigators

Ahmed I Elbassiouny, MD (1)  ·  Grethe Andersen, M.D Doctor (1)  ·  Hala M Elkhawas, MD (1)  ·  Hani Mohamed M Aref, MD (1)  ·  Hossam S Mohammed, MD (1)  ·  Jean M Orgogozo, MD (1)  ·  M G Hennerici, MD (1)  ·  Mohamed Zeinhom M Gomaa, M.Sc. (1)  ·  Suyue Pan, M.D., Ph.D. (1)  ·  Tamer M Roushdy, MD (1)  ·  Vijay K Sharma, MD (1)  ·  Yves Samson, MD,PhD (1)

Results publications

PMID 16614616, PMID 17126719, PMID 22700528, PMID 24203849, PMID 25793765, PMID 27160892, PMID 30290680, PMID 32527232, PMID 34515113, PMID 36446950, PMID 37965431